{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:39:14Z","timestamp":1775072354190,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003213","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T22:35:57Z","timestamp":1466721357000},"page":"e3213","source":"Crossref","is-referenced-by-count":19,"title":["A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA)"],"prefix":"10.1097","volume":"95","author":[{"given":"Fei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R2-20-20210226","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11926-010-0135-9","article-title":"Giant cell arteritis: epidemiology, diagnosis, and management","volume":"12","author":"Gonzalez-Gay","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"R3-20-20210226","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R4-20-20210226","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.2009.177220","article-title":"Giant cell arteritis in Asians: a comparative study","volume":"95","author":"Pereira","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R5-20-20210226","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","article-title":"Clinical features of polymyalgia rheumatica and giant cell arteritis","volume":"8","author":"Salvarani","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R6-20-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/000331970205300413","article-title":"Giant cell arteritis in China: a prospective investigation","volume":"53","author":"Hu","year":"2002","journal-title":"Angiology"},{"key":"R7-20-20210226","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/000331970005101108","article-title":"Temporal arteritis and fever: report of a case and a clinical reanalysis of 360 cases","volume":"51","author":"Hu","year":"2000","journal-title":"Angiology"},{"key":"R8-20-20210226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/000331970405500218","article-title":"Cerebral infarction due to giant cell arteritis-three case reports","volume":"55","author":"Hu","year":"2004","journal-title":"Angiology"},{"key":"R9-20-20210226","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1445-5994.1991.tb01384.x","article-title":"Giant cell arteritis in two Chinese patients","volume":"21","author":"Wing","year":"1991","journal-title":"Aust N Z J Med"},{"key":"R10-20-20210226","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/art.1780270127","article-title":"Giant cell arteritis in two Chinese patients","volume":"27","author":"Wilske","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R11-20-20210226","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R12-20-20210226","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/rheumatology\/ker329","article-title":"Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study","volume":"51","author":"Ghinoi","year":"2012","journal-title":"Rheumatology (Oxford"},{"key":"R14-20-20210226","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study","volume":"26","author":"Gonzalez-Gay","year":"1999","journal-title":"J Rheumatol"},{"key":"R15-20-20210226","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"R16-20-20210226","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"R17-20-20210226","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/art.20523","article-title":"Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R18-20-20210226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore"},{"key":"R19-20-20210226","doi-asserted-by":"crossref","first-page":"A544","DOI":"10.1016\/j.autrev.2012.01.003","article-title":"Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment","volume":"11","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R20-20-20210226","first-page":"1219","article-title":"Sex differences in giant cell arteritis","volume":"29","author":"Nir-Paz","year":"2002","journal-title":"J Rheumatol"},{"key":"R21-20-20210226","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/35.11.1161","article-title":"A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis","volume":"35","author":"Myklebust","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R22-20-20210226","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R23-20-20210226","doi-asserted-by":"crossref","first-page":"317","DOI":"10.6061\/clinics\/2013(03)OA06","article-title":"Giant cell arteritis: a multicenter observational study in Brazil","volume":"68","author":"Souza","year":"2013","journal-title":"Clinics (Sao Paulo"},{"key":"R24-20-20210226","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Smetana","year":"2002","journal-title":"JAMA"},{"key":"R25-20-20210226","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore"},{"key":"R26-20-20210226","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.11195","article-title":"Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey","volume":"49","author":"Kobayashi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R27-20-20210226","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","article-title":"High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition","volume":"48","author":"Berger","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R28-20-20210226","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","article-title":"Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis","volume":"48","author":"Salvarani","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R30-20-20210226","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore"},{"key":"R31-20-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine (Baltimore"},{"key":"R32-20-20210226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R33-20-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.md.0000119761.27564.c9","article-title":"Risk factors for cranial ischemic complications in giant cell arteritis","volume":"83","author":"Nesher","year":"2004","journal-title":"Medicine (Baltimore"},{"key":"R34-20-20210226","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"R35-20-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R36-20-20210226","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0161-6420(98)91033-8","article-title":"Scalp necrosis with giant cell arteritis","volume":"105","author":"Dudenhoefer","year":"1998","journal-title":"Ophthalmology"},{"key":"R37-20-20210226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MD.0b013e3181af4518","article-title":"Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine (Baltimore"},{"key":"R38-20-20210226","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000030185.67510.C0","article-title":"Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis","volume":"106","author":"Cid","year":"2002","journal-title":"Circulation"},{"key":"R39-20-20210226","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ije\/18.4.836","article-title":"A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?","volume":"18","author":"Machado","year":"1989","journal-title":"Int J Epidemiol"},{"key":"R40-20-20210226","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X","article-title":"Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l\u2019Arterite a Cellules Geantes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:20:59Z","timestamp":1620958859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603290-00020"}},"subtitle":["Clinical Features and Factors Associated With Severe Ischemic Manifestations"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003213","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}